Fig. 3From: Evaluation of novel coronavirus disease (COVID-19) using quantitative lung CT and clinical data: prediction of short-term outcomeExample of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lung disease segmentation. Typical SARS-CoV-2 pneumonia with lung opacities before (a) and after (b) semiautomatic segmentationBack to article page